 鲜花( 85)  鸡蛋( 2)
|

楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval) q, c0 E2 W2 z; m( ~5 ~6 Z
: L l9 ]) X# S G6 qEDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.
( @6 Q+ i3 M) [2 d6 b( i
1 b! J8 I+ i1 Q, X+ a; J# NBY THE EDMONTON JOURNAL FEBRUARY 16, 20077 S% c$ C+ ~' a3 G0 `3 L/ W3 H# h
( Z' N0 W& _" I( F/ C8 `
$ y# Y2 P( I6 a LEDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.( N- g$ }1 I, J- g
e2 f+ b* e* K, c
The agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM.", y, b) Y0 }5 Z' E0 \ d z: y
/ S r8 h, T& wThe APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product.* ]: @) {% E! l
4 m- q( h, @8 uIt should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday.6 c* O+ }) G# D. M3 i) x
4 ^! d7 Q% B: s' b6 p4 h6 ~% M, v
It certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million.
; Z! P0 a" j/ t4 L% i# y8 g
0 R; I9 s) ^8 p) f4 _"As a scientist, it's one of the highlights of my CAREER," Shan said.
6 `6 a; L6 Z/ x3 f0 i3 z3 a' ~1 m7 ]" Q+ c9 Y1 H
"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention."* r% L! Q& a/ S% @$ _
4 \) i [/ s* D, d
It's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.( B" o+ I# Z0 H: z6 Z* S( ?
# S( @! x# j( X" @, j) h! H0 aGinseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.
/ C2 n: A" J0 E7 {
* ]' [: g. Q- d2 S4 UThe approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman.
/ Q. o, B1 u* [3 S) ?+ m/ M. C, V( W- E1 B
1 @1 T# K5 w! n4 O- y% ~8 Q; C, chttp://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|